Li‐Tzu Wang

1.2k total citations · 1 hit paper
30 papers, 816 citations indexed

About

Li‐Tzu Wang is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, Li‐Tzu Wang has authored 30 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 10 papers in Immunology and 8 papers in Surgery. Recurrent topics in Li‐Tzu Wang's work include Mesenchymal stem cell research (13 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Reproductive System and Pregnancy (3 papers). Li‐Tzu Wang is often cited by papers focused on Mesenchymal stem cell research (13 papers), Tissue Engineering and Regenerative Medicine (4 papers) and Reproductive System and Pregnancy (3 papers). Li‐Tzu Wang collaborates with scholars based in Taiwan, United States and China. Li‐Tzu Wang's co-authors include B. Linju Yen, Ming‐Shyen Yen, Ko‐Jiunn Liu, Huey‐Kang Sytwu, Kenneth K. Wu, Kevin Sheng‐Kai, Chia‐Chi Chang, Shih Sheng Jiang, Kevin Sheng-Kai and James Cheng‐Chung Wei and has published in prestigious journals such as Applied Physics Letters, The Journal of Immunology and Biomaterials.

In The Last Decade

Li‐Tzu Wang

28 papers receiving 805 citations

Hit Papers

Human mesenchymal stem cells (MSCs) for treatment towards... 2016 2026 2019 2022 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐Tzu Wang Taiwan 13 399 244 199 134 85 30 816
Lisa Boyette United States 5 244 0.6× 212 0.9× 137 0.7× 183 1.4× 73 0.9× 7 717
S. Jyothi Prasanna India 6 609 1.5× 311 1.3× 280 1.4× 297 2.2× 178 2.1× 8 1.1k
Darling Rojas-Canales Australia 14 261 0.7× 347 1.4× 310 1.6× 323 2.4× 82 1.0× 27 994
Gunter Kerst Germany 18 222 0.6× 298 1.2× 228 1.1× 176 1.3× 106 1.2× 64 1.2k
Kaitlin C. Clark United States 16 541 1.4× 264 1.1× 362 1.8× 43 0.3× 64 0.8× 24 981
Ludy Dobrila United States 8 472 1.2× 220 0.9× 219 1.1× 136 1.0× 121 1.4× 24 984
Szu‐Yu Chen United States 24 240 0.6× 359 1.5× 244 1.2× 82 0.6× 55 0.6× 45 1.7k
Motonori Okabe Japan 21 346 0.9× 302 1.2× 608 3.1× 170 1.3× 88 1.0× 60 1.5k
Marta Kot Poland 13 298 0.7× 273 1.1× 213 1.1× 33 0.2× 61 0.7× 40 803
Timur Fatkhudinov Russia 19 278 0.7× 318 1.3× 328 1.6× 417 3.1× 107 1.3× 139 1.5k

Countries citing papers authored by Li‐Tzu Wang

Since Specialization
Citations

This map shows the geographic impact of Li‐Tzu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Tzu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Tzu Wang more than expected).

Fields of papers citing papers by Li‐Tzu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Tzu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Tzu Wang. The network helps show where Li‐Tzu Wang may publish in the future.

Co-authorship network of co-authors of Li‐Tzu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Tzu Wang. A scholar is included among the top collaborators of Li‐Tzu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Tzu Wang. Li‐Tzu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yuan, et al.. (2025). Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials. Stem Cell Research & Therapy. 16(1). 3–3. 8 indexed citations
3.
Wang, Li‐Tzu, et al.. (2025). Zirconia Minimizes Myeloid Innate Immunity as Dental Implants: An In Silico and In Vivo Study. Clinical Oral Implants Research. 36(12). 1626–1639.
4.
Wang, Li‐Tzu, Shih Sheng Jiang, Ko‐Jiunn Liu, et al.. (2025). Lack of IFN-γ response of human uterine myometrium-derived MSCs significantly improve multiple IBD parameters compared to bone marrow MSCs: Implications for anti-TNFα-refractory patients. Pharmacological Research. 215. 107716–107716. 1 indexed citations
5.
Wang, Li‐Tzu, Chyn‐Tair Lan, Wei-An Chen, et al.. (2025). Titanium implants trigger extra-periodontal T cell-mediated immunity. Biomaterials Science. 13(6). 1543–1553. 2 indexed citations
6.
Sheng‐Kai, Kevin, Li‐Tzu Wang, Naoko Sasamoto, et al.. (2024). Endometriosis and Sjögren's syndrome: Bidirectional associations in population‐based 15‐year retrospective cohorts. Acta Obstetricia Et Gynecologica Scandinavica. 103(10). 2070–2080. 4 indexed citations
7.
Wang, Li‐Tzu, et al.. (2024). Single-cell analysis of peri-implant gingival tissue to assess implant biocompatibility and immune response. Journal of Prosthodontic Research. 69(1). 97–109. 3 indexed citations
8.
Yen, B. Linju, et al.. (2024). Excess glucose alone depress young mesenchymal stromal/stem cell osteogenesis and mitochondria activity within hours/days via NAD+/SIRT1 axis. Journal of Biomedical Science. 31(1). 49–49. 8 indexed citations
9.
Sheng‐Kai, Kevin, et al.. (2023). Exposure to environmental air pollutants as a risk factor for primary Sjögren’s syndrome. Frontiers in Immunology. 13. 1044462–1044462. 13 indexed citations
10.
Huang, Jing‐Yang, Kevin Sheng‐Kai, Li‐Tzu Wang, et al.. (2023). The Risk of Endometrial Cancer and Uterine Sarcoma Following Endometriosis or Pelvic Inflammatory Disease. Cancers. 15(3). 833–833. 10 indexed citations
11.
Yen, B. Linju, et al.. (2023). Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State. Stem Cells Translational Medicine. 12(5). 235–244. 53 indexed citations
13.
Chen, Yiwen, et al.. (2022). Age-dependent oral manifestations of neurofibromatosis type 1: a case–control study. Orphanet Journal of Rare Diseases. 17(1). 93–93. 12 indexed citations
14.
Wang, Li‐Tzu, B. Linju Yen, Ying-Yin Chao, et al.. (2022). Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome. Thorax. 78(5). 504–514. 14 indexed citations
16.
Wang, Li‐Tzu, et al.. (2021). A Rapid and Highly Predictive in vitro Screening Platform for Osteogenic Natural Compounds Using Human Runx2 Transcriptional Activity in Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology. 8. 607383–607383. 8 indexed citations
17.
Sheng‐Kai, Kevin, Chien‐Chang Lee, Ko‐Jiunn Liu, et al.. (2021). Safety and Seroconversion of Immunotherapies against SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis of Clinical Trials. Pathogens. 10(12). 1537–1537. 12 indexed citations
18.
Wang, Li‐Tzu, Ko‐Jiunn Liu, Huey‐Kang Sytwu, Ming‐Shyen Yen, & B. Linju Yen. (2021). Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human pluripotent Stem Cell-Derived Mesenchymal Stem Cells. Stem Cells Translational Medicine. 10(9). 1288–1303. 88 indexed citations
19.
Wang, Li‐Tzu, Li-Yueh Huang, Sheng-Kang Chiu, et al.. (2020). Human Placental MSC-Secreted IL-1β Enhances Neutrophil Bactericidal Functions during Hypervirulent Klebsiella Infection. Cell Reports. 32(13). 108188–108188. 23 indexed citations
20.
Wang, Li‐Tzu, Ming‐Shyen Yen, Ko‐Jiunn Liu, et al.. (2016). Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. Journal of Biomedical Science. 23(1). 76–76. 267 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026